Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0293605 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Acharya Balkrishna und 8 weiteren Autor:innen. Beteiligte Einrichtung: Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India. Hauptthemen laut MEDLINE: Vancomycin, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vancomycin, is widely used against methicillin-resistant bacterial infections. However, Vancomycin accumulation causes nephrotoxicity which leads to an impairment in the filtration mechanisms of kidney. Traditional herbal medicines hold potential for treatment of drug-induced nephrotoxicity. Herein, we investigated protective properties of plant-based medicine Renogrit against Vancomycin-induced kidney injury. Phytometabolite analysis of Renogrit was performed by UHPLC. Spheroids formed from human proximal tubular cell (HK-2) were used for in vitro evaluation of Vancomycin-induced alterations in cell viability, P-gp functionality, NAG, KIM-1 levels, and mRNA expression of NGAL and MMP-7. The in vivo efficacy of Renogrit against Vancomycin-induced nephrotoxicity was further evaluated in Sprague-Dawley (SD) rats by measurement of BUN, serum creatinine, and their respective clearances. Moreover, eGFR, kidney-to-body weight ratio, GSH/GSSG ratio, KIM-1, NAG levels and mRNA expression of KIM-1 and osteopontin were also analyzed. Changes in histopathology of kidney and hematological parameters were also observed. Renogrit treatment led to an increase in cell viability, normalization of P-gp functionality, decrease in levels of NAG, KIM-1, and reduction in mRNA expression of NGAL and MMP-7. In Vancomycin-challenged SD rats, Renogrit treatment normalized altered kidney functions, histological, and hematological parameters. Our findings revealed that Renogrit holds a clinico-therapeutic potential for alleviating Vancomycin-associated nephrotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Drug Discovery and Development Division, Patanjali Research Foundation, Haridwar, Uttarakhand, India.
- Department of Allied and Applied Sciences, University of Patanjali, Haridwar, Uttarakhand, India.
- Patanjali Yog Peeth (UK) Trust, Glasgow, United Kingdom.
- Special Centre for Systems Medicine, Jawaharlal Nehru University, New Delhi, India.
ORCID-Profile: Anurag Varshney
Zitieren
APA
Balkrishna, A., Sharma, S., Gohel, V., Kumari, A., Rawat, M., Maity, M., Sinha, S., Dev, R., & Varshney, A. (2023). Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance. PLOS ONE. https://doi.org/10.1371/journal.pone.0293605
Vancouver
Balkrishna A, Sharma S, Gohel V, Kumari A, Rawat M, Maity M, et al. Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance. PLOS ONE. 2023. doi:10.1371/journal.pone.0293605
BibTeX
@article{Balkrishna2023,
author = {Balkrishna, Acharya and Sharma, Sonam and Gohel, Vivek and Kumari, Ankita and Rawat, Malini and Maity, Madhulina and Sinha, Sandeep and Dev, Rishabh and Varshney, Anurag},
title = {Renogrit attenuates Vancomycin-induced nephrotoxicity in human renal spheroids and in Sprague-Dawley rats by regulating kidney injury biomarkers and creatinine/urea clearance},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0293605}
}
EUVIMED